Hublo, a Paris-based supplier of workforce administration software program options for the healthcare sector, has raised acquired a €40 million reinvestment automobile from development funding agency Revaia.
This funding will assist Hublo in a brand new part following its sale in 2025, aiming to increase assist for the corporate past the preliminary holding interval.
This follows 2025’s shut of Revaia Development II fund at €250 million, as covered by EU-Startups.com.
Antoine Loron, co-founder and co-CEO of Hublo, added: “Revaia’s continued dedication to us is a continuation of a long-term partnership constructed on belief and alignment. Their resolution to reinvest alongside our new majority shareholder demonstrates their perception in our trajectory and strengthens the steadiness of our shareholder base for the subsequent stage of our improvement.”
Exercise throughout 2025 and early 2026 factors to continued however usually smaller-scale funding exercise throughout adjoining areas of European HealthTech in comparison with Hublo’s €40 million reinvestment.
In September 2025, Warsaw-based Doctor.One raised €4 million to increase its asynchronous care platform for power sufferers into extra European markets, whereas Antwerp startup Mindoo secured €5 million in Seed funding to scale back administrative workload for hospital and medical employees utilizing AI brokers, inserting it closest thematically to Hublo’s concentrate on operational effectivity for healthcare professionals. In Switzerland, Zurich-based Ahead Health raised €5.1 million to scale its preventive healthcare companies by means of clinic partnerships, whereas UK longevity startup GlycanAge closed a €7.4 million spherical to commercialise glycan-based ageing diagnostics.
Taken collectively, these adjoining healthtech rounds quantity to roughly €21.5 million, underscoring that Hublo’s reinvestment automobile is materially bigger than most up-to-date European HealthTech financings and displays a later-stage, ownership-driven dedication moderately than main development capital alone.
Alice Albizzati, Founding Companion of Revaia, acknowledged: “This reinvestment automobile extends the assist we now have offered to Hublo since 2021 and displays our confidence within the high quality of the workforce and the corporate’s trajectory, whereas additionally permitting us to usher in new buyers for the subsequent part of worth creation.”
Based in 2016, Hublo was born from the merger of Whoog and MedGo in the course of the peak of the Covid disaster – addressing structural healthcare employees shortages. Its platform permits healthcare establishments to effectively handle staffing, from recruitment to scheduling, inner mobility, and communication.
The answer reportedly centralises and optimises the ad-hoc and recurring staffing wants of hospitals, clinics, nursing properties, and healthcare suppliers. By 2025, Hublo was being utilized by over 22,000 managers in additional than 5,000 amenities, benefiting 1 million healthcare professionals, with a mean saving of two.5 hours per day per person.
Having acquired a big stake in July 2021, when Hublo was already establishing itself as a participant within the digitalisation of workforce administration for healthcare amenities, Revaia supported the corporate in its enlargement and scaling-up technique.
This assist was structured round three key levers:
- Extending the product providing to a complete workforce and expertise administration platform
- Strengthening the go-to-market technique with private and non-private establishments
- Implementing a proactive sector consolidation technique, which included three acquisitions that had been built-in throughout this era.
This momentum enabled Hublo to quadruple its annual recurring income and attain operational break-even forward of schedule. 5 Arrows, the choice asset funding arm of Rothschild & Co, finalised its strategic funding in July 2025 following a aggressive course of. This sale marks the primary exit for the Revaia Development I fund.
The reinvestment automobile raised by Revaia brings collectively European, UK and US buyers and permits each present Revaia buyers and new entrants to speculate alongside the brand new shareholder and administration workforce.
